Aarhus University Seal / Aarhus Universitets segl

News

News

Jørgen Kjems (left) og Morten T. Venø describes in an article in PNAS, how expression of non-coding RNA changes during epileptic seizures in rodents (Photo: Anne Færch Nielsen)

2020.06.25 | Research, Knowledge exchange

Large-scale data sets identify small RNAs with a role in epilepsy

A new paper from Jørgen Kjems' group at iNANO and MBG describes how expression of non-coding RNA changes during epileptic seizures in rodents. The authors found that inhibiting a specific set of microRNAs (miRNAs) by antisense technology reduced seizure frequency in a mouse model, suggesting that these RNA molecules could serve as possible targets…

Joseph A. Lyons receives DKK 10 million from Lundbeckfonden to study lipid transport (photo: Lisbeth Heilesen)

2020.06.16 | Grant

Joseph Lyons receives DKK 10 million from Lundbeckfonden to study cell membranes

Joseph Lyons is one of the nine talented researchers who will become a Lundbeckfonden fellow in 2020. And the grant that comes with the appointment enables him to establish his own research group and devote himself to research for the next five years at the Department of Molecular Biology and Genetics/DANDRITE, Aarhus University.

Together with researchers from The Crick Institute in the UK, Hans Henrik Gad (left) and Rune Hartmann have published results in Science describing how an immune response prevents the rebuilding of damaged lung tissue after infection with viruses such as influenza and SARS-CoV-2. Photo: Lisbeth Heilesen

2020.06.11 | Research

Signal substance that can potentially be used to treat COVID-19 also has negative effects

It is difficult wage war without causing collateral damage , and the same goes for our immune system when it has to fight viral infections, such as influenza and COVID-19. Research by a team from The Crick Institute and Aarhus University describes how an immune response prevents the rebuilding of damaged lung tissue after infection with viruses…

A project team from Aarhus University and Fida Biosystems will use advanced microfluidic techniques in the search for compounds, which can block the contact between SARS-CoV-2 virus and receptors on human cells. Click on the graphic to see it full size (Graphics by Daniel Otzen)
Daniel Otzen is heading a collaborative project with DKK 3.8 million from the Innovation Fund Denmark for combating COVID-19. Photo: Jesper Rais, AU.

2020.06.02 | Grant

Newly established cooperation receives funding to combat COVID-19

Daniel Otzen and collaborators, Jørgen Kjems and Victoria Birkedal from the Interdisciplinary Nanoscience Center (iNANO) and the company Fida Biosystems, have received DKK 3.8 million from the Innovation Fund Denmark to develop a screening system to identify drugs that are able to combat COVID-19.